3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2/3
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
43
NIH
31
INDUSTRY
3
NETWORK
2
OTHER_GOV
1
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
12
Thoracic
9
Genitourinary
8
Lymphoid
7
Breast
7
Sarcoma
5
Other hematologic neoplasm
4
Head & Neck
3
Plasma cell
2
Gynecologic
2
Gastrointestinal
2
Other solid neoplasm
1
Dermatologic
1
Conditions
Uterine Cervical Neoplasms
1
Peritoneal Neoplasms
1
Interventions
Cisplatin
63
Paclitaxel
56
Carboplatin
38
Taxes
24
Radiotherapy
21
Gemcitabine
16
Brachytherapy
15
Filgrastim
14
Doxorubicin
13
Topotecan
12
Platinum
12
1,2-diaminocyclohexaneplatinum II citrate
12
Docetaxel
11
Radiation
7
Granulocyte Colony-Stimulating Factor
7
Chemotherapy, Adjuvant
7
pegfilgrastim
6
Surgical Procedures, Operative
6
Radiotherapy, Intensity-Modulated
6
Polymerase Chain Reaction
6
Ifosfamide
6
Etoposide
6
Watchful Waiting
5
Radiotherapy, Conformal
5
Pemetrexed
5
Gene Expression Profiling
5
Fluorouracil
5
Celecoxib
5
Amifostine
5
Observation
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
NETWORK
×
Magnetic Resonance Spectroscopy
×
Gynecologic
×
Clear all
NCT07001748
2026-05-15
STOPGAP II
Eastern Cooperative Oncology Group
Phase 2/3
Recruiting
148 enrolled
NCT00004936
2013-01-28
ACRIN 6651
American College of Radiology Imaging Network
Phase NA
Completed